Ignite Creation Date:
2024-05-05 @ 10:01 PM
Last Modification Date:
2024-10-26 @ 10:12 AM
Study NCT ID:
NCT01012414
Status:
TERMINATED
Last Update Posted:
2014-05-20
First Post:
2009-11-11
Brief Title:
Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
Sponsor:
Thomas Jefferson University
Organization:
Thomas Jefferson University
Study Overview
Official Title:
The Effect of Vitamin D Supplementation on Markers of Inflammation in High-Risk Cardiovascular Patients With Low Levels of Serum 25-Hydroxyvitamin D
Status:
TERMINATED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Futility in enrollment as of May 31 2011
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VINCA-CKD
Brief Summary:
The purpose of this study is to determine if vitamin D supplementation changes the results of certain tests associated with inflammation in the body using an oral synthetic form of vitamin D called paricalcitol
Detailed Description:
Vitamin D deficiency is common and has been associated with an increased risk of heart disease In patients with the combination of kidney disease and heart disease inflammation is thought to contribute to a high rate of cardiac events Less is known about the effects of vitamin D supplementation on certain tests associated with inflammation in the body
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None